Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.4.16 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.70NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.428NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.374NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.63 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.377NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.298NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.30.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.76NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.17.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.562NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.219NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AZ.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.114NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.516NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.354NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.162NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.426NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.402NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.424NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.264NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.581NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.330NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FW.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.422NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.507NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.178NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.273NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.211NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.474NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used